← Back to Search

Music and Theta Auditory Beat Stimulation (ABS) for Dementia

N/A

Waitlist Available

Led By Adiel Mallik, PhD

Research Sponsored by Lucid, Inc.

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Mild to Moderate Dementia (mild: Montreal Cognitive Assessment (MOCA) scores (18-25); moderate: MOCA scores (10-17)))

Be older than 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 30 minutes

Awards & highlights

Study Summary

This trial will test if a new personalized AI music system with binaural beats can reduce anxiety and agitation in people with dementia, compared to a control condition of audiobooks. Caregivers will assess participants' anxiety, agitation, and mood before and after 4 one-hour sessions over 2 weeks. #dementia #musictherapy

Eligible Conditions

Dementia

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 30 minutes

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~30 minutes

This trial's timeline: 3 weeks for screening, Varies for treatment, and 30 minutes for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Cohen Mansfield Agitation Index

Secondary outcome measures

Cornell Brown Scale for Quality of Life in Dementia

Digit Span Forward

Overt Agitation Severity Scale

+3 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Music and Theta Auditory Beat Stimulation (ABS)Experimental Treatment1 Intervention

Participants listen to 30 minutes of personalized music with theta auditory beat stimulation (ABS).

Group II: AudiobooksActive Control1 Intervention

Participants listen to a 30-minute audiobook.

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

Lucid, Inc.Lead Sponsor

4 Previous Clinical Trials

654 Total Patients Enrolled

Adiel Mallik, PhDPrincipal InvestigatorLucid, Inc.

1 Previous Clinical Trials

100 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this trial encompass people aged sixty or above?

"This medical trial requires participants to be aged between 65 and 85 years old, in compliance with the inclusion criteria."

Answered by AI

Who is eligible to be a part of this medical experiment?

"Candidates between 65 and 85 years of age with a diagnosis of dementia are eligible for this trial. The recruitment goal is to have 48 participants in total."

Answered by AI

Are researchers still recruiting participants for this research initiative?

"Affirmative, information available on clinicaltrials.gov implies that this medical trial is currently recruiting participants. The study was first posted on May 8th 2023 and its parameters have been recently modified. It seeks 48 individuals from a single site."

Answered by AI

What is the current population size of participants involved in this clinical experiment?

"Affirmative. According to clinicaltrials.gov, this medical trial which was first announced on May 8th 2023 is currently looking for participants. There are 48 spots available at 1 site."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

The Effect of Auditory Interventions on Anxiety and Agitation in People With Dementia

2023. "The Effect of Auditory Interventions on Anxiety and Agitation in People With Dementia". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05844241.